Skip to content

Clinical trials

Immunoblastic Lymphadenopathy trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20072
20091
20121
20182
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK3
Autolus Limited1
Cancer Research Campaign Clinical Trials Centre1
Clatterbridge Centre for Oncology1
European Organisation for Research and Treatment of Cancer - EORTC1
Royal Marsden NHS Foundation Trust1
SecuraBio1
The Lymphoma Academic Research Organisation1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy11
Lymphoma7
Lymphoma, Large-Cell, Anaplastic6
Burkitt Lymphoma4
Hodgkin Disease4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Large-Cell, Immunoblastic4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma4
Intraocular Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.